UBX

Unity Biotechnology
UBX

Overview Fund Activity
Delisted

UBX was delisted on the 8th of July, 2025.

Back to rankings

92 hedge funds and large institutions have $122M invested in Unity Biotechnology in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 27 reducing their positions, and 10 closing their positions.

Holders
92
Holders Change
+7
Holders Change %
+8.24%
% of All Funds
1.62%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
20
Reduced
27
Closed
10
Calls
$1.03M
Puts
$761K
Net Calls
+$268K
Net Calls Change
+$146K

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$3.45M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$727K
3
Axa
3
Axa
France
$709K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$3.33M
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$398K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$24.7M
2
Morgan Stanley
2
Morgan Stanley
New York
$1.01M
3
CCM
3
CAAS Capital Management
New York
$0
4
Jane Street
4
Jane Street
New York
$0
5
Russell Investments Group
5
Russell Investments Group
United Kingdom
$1.11M
Name Market Value Shares Shares
Change 		Shares
Change %
LC
101
Lindbrook Capital
California
$0 40 – –
SO
102
STRS Ohio
Ohio
$0 100 – –
CFGS
103
Concourse Financial Group Securities
Alabama
– – – –
WIM
104
Westside Investment Management
California
$0 100 – –
HT
105
HAP Trading
New York
– – – –
IA
106
IFP Advisors
Florida
– – – –
1 2 3 4
5